Tomasz Blicharski Lubelskie Centrum Diagnostyczne

Verified siteinfo

Poland Ul. Drewniana 61, 21-040 Swidnik, Poland

3 trials recruiting
Osteoarthritis · Dermatitis atopic · Obesity
Adults and children

About Specializations

Tomasz Blicharski Lubelskie Centrum Diagnostyczne in Swidnik, Poland specialises in clinical trials of conditions such as Osteoarthritis, Dermatitis atopic, Obesity, Cardiovascular disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Skin and Connective Tissue Diseases

At Tomasz Blicharski Lubelskie Centrum Diagnostyczne, clinical research is focused on skin and connective tissue diseases, with a clear emphasis on atopic dermatitis. The studies are designed to evaluate a potential new therapy and better understand its impact on people living with moderate to severe symptoms.

Research centered on atopic dermatitis and related dermatologic care
Trials aimed at testing the clinical effectiveness of a new treatment approach
Work that supports improved management of inflammatory skin disease

This site contributes to dermatology research by helping assess whether an investigational treatment can offer meaningful benefit for patients with persistent skin inflammation.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Drewniana 6121-040 SwidnikPoland

Open in maps ↗

Recruiting now: 3 trials
Conditions studied: 10
Partner status: Verified site

More sites in Swidnik Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

12 clinical trials

Cardiovascular disorder+1

Recruiting

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Zilebesiran
Sponsor:Alnylam Pharmaceuticals Inc.

Contact Research Centre

Obesity

Recruiting

Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

Investigational

Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Heart failure with reduced ejection fraction

Recruiting

Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

Investigational

Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Omecamtiv mecarbil
Sponsor:Cytokinetics Inc.

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Study on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis

Registered drug

Study on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis

Registered drug

Poland

Participants:18–64 years
Substances:ANB032
Sponsor:Anaptysbio Inc.

Contact Research Centre

Psoriasis

Not recruiting

Study on the Effects of IDP-118 Lotion (Tazarotene and Halobetasol Propionate) for Children with Moderate to Severe Plaque Psoriasis

InvestigationalNo placebo

Study on the Effects of IDP-118 Lotion (Tazarotene and Halobetasol Propionate) for Children with Moderate to Severe Plaque Psoriasis

InvestigationalNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tazarotene
Sponsor:Bausch Health Americas Inc.

Contact Research Centre

Neuralgia

Not recruiting

Study on Capsaicin for Treating Post-Surgical Neuropathic Pain in Patients

Registered drugNo placebo

Study on Capsaicin for Treating Post-Surgical Neuropathic Pain in Patients

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capsaicin
Sponsor:Averitas Pharma Inc.

Contact Research Centre

Osteoarthritis

Not recruiting

Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

Registered drugNo placebo

Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Resiniferatoxin
Sponsor:Gruenenthal GmbH

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

Registered drug